Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Variation in care in pediatric Crohn disease.

Colletti RB, Baldassano RN, Milov DE, Margolis PA, Bousvaros A, Crandall WV, Crissinger KD, D'Amico MA, Day AS, Denson LA, Dubinsky M, Ebach DR, Hoffenberg EJ, Kader HA, Keljo DJ, Leibowitz IH, Mamula P, Pfefferkorn MD, Qureshi MA; Pediatric IBD Network for Research and Improvement.

J Pediatr Gastroenterol Nutr. 2009 Sep;49(3):297-303. doi: 10.1097/MPG.0b013e3181919695.

PMID:
19590456
2.

Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.

Banerjee S, Bishop WP.

J Pediatr Gastroenterol Nutr. 2006 Sep;43(3):324-30.

PMID:
16954954
3.

Genetic testing in Crohn disease: utility in individualizing patient management.

Mascheretti S, Schreiber S.

Am J Pharmacogenomics. 2005;5(4):213-22. Review.

PMID:
16078858
4.
5.

Intercenter variation in initial management of children with Crohn's disease.

Kappelman MD, Bousvaros A, Hyams J, Markowitz J, Pfefferkorn M, Kugathasan S, Rosh J, Otley A, Mack D, Griffiths A, Evans J, Grand R, Langton C, Kleinman K, Finkelstein JA.

Inflamm Bowel Dis. 2007 Jul;13(7):890-5.

PMID:
17286275
6.

Infliximab therapy in children with concurrent perianal Crohn disease: observations from REACH.

Crandall W, Hyams J, Kugathasan S, Griffiths A, Zrubek J, Olson A, Liu G, Heuschkel R, Markowitz J, Cohen S, Winter H, Veereman-Wauters G, Ferry G, Baldassano RN.

J Pediatr Gastroenterol Nutr. 2009 Aug;49(2):183-90. doi: 10.1097/MPG.0b013e3181a70f21.

PMID:
19561542
7.

Thiopurine dose in intermediate and normal metabolizers of thiopurine methyltransferase may differ three-fold.

Gardiner SJ, Gearry RB, Begg EJ, Zhang M, Barclay ML.

Clin Gastroenterol Hepatol. 2008 Jun;6(6):654-60; quiz 604. doi: 10.1016/j.cgh.2008.02.032. Epub 2008 May 7.

PMID:
18467186
8.

Consensus and controversy in the management of pediatric Crohn disease: an international survey.

Levine A, Milo T, Buller H, Markowitz J.

J Pediatr Gastroenterol Nutr. 2003 Apr;36(4):464-9.

PMID:
12658036
9.

Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.

Fargher EA, Tricker K, Newman W, Elliott R, Roberts SA, Shaffer JL, Bruce I, Payne K.

J Clin Pharm Ther. 2007 Apr;32(2):187-95.

PMID:
17381669
10.

Adherence to thiopurine treatment in out-patients with Crohn's disease.

Bokemeyer B, Teml A, Roggel C, Hartmann P, Fischer C, Schaeffeler E, Schwab M.

Aliment Pharmacol Ther. 2007 Jul 15;26(2):217-25.

11.

Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease.

Oliva-Hemker MM, Abadom V, Cuffari C, Thompson RE.

J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):180-4.

PMID:
17255828
12.

Effects of infliximab and parenteral nutrition on albumin and fibrinogen synthesis rates in pediatric Crohn disease.

Steiner SJ, Pfefferkorn MD, Fitzgerald JF, Denne SC.

J Pediatr Gastroenterol Nutr. 2008 Nov;47(5):579-84.

PMID:
18979581
13.

Gastroenterologists' prescribing of infliximab for Crohn's disease: a national survey.

St Charles M, Smith SR, Beardsley R, Fedder DO, Carter-Pokras O, Cross RK.

Inflamm Bowel Dis. 2009 Oct;15(10):1467-75. doi: 10.1002/ibd.20904.

PMID:
19266574
14.

Initial clinical experience with allopurinol-thiopurine combination therapy in pediatric inflammatory bowel disease.

Rahhal RM, Bishop WP.

Inflamm Bowel Dis. 2008 Dec;14(12):1678-82. doi: 10.1002/ibd.20522.

PMID:
18521913
15.

Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms.

Pfefferkorn M, Burke G, Griffiths A, Markowitz J, Rosh J, Mack D, Otley A, Kugathasan S, Evans J, Bousvaros A, Moyer MS, Wyllie R, Oliva-Hemker M, Carvalho R, Crandall W, Keljo D, Walters TD, LeLeiko N, Hyams J.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):168-74. doi: 10.1097/MPG.0b013e318175ca7f.

PMID:
19179878
16.

How are Azathioprine and 6-mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice.

Yip JS, Woodward M, Abreu MT, Sparrow MP.

Inflamm Bowel Dis. 2008 Apr;14(4):514-8.

PMID:
18088072
17.

Capsule endoscopy in the evaluation of patients with unexplained growth failure.

Moy L, Levine J.

J Pediatr Gastroenterol Nutr. 2009 May;48(5):647-50. doi: 10.1097/MPG.0b013e31818b0ac7.

PMID:
19367183
18.

Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.

Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.

J Pediatr Gastroenterol Nutr. 2009 May;48(5):526-30. doi: 10.1097/MPG.0b013e318196df3e.

PMID:
19412004
19.

Evaluation of the pediatric crohn disease activity index: a prospective multicenter experience.

Hyams J, Markowitz J, Otley A, Rosh J, Mack D, Bousvaros A, Kugathasan S, Pfefferkorn M, Tolia V, Evans J, Treem W, Wyllie R, Rothbaum R, del Rosario J, Katz A, Mezoff A, Oliva-Hemker M, Lerer T, Griffiths A; Pediatric Inflammatory Bowel Disease Collaborative Research Group.

J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):416-21.

PMID:
16205508
20.

Influence of xanthine oxidase on thiopurine metabolism in Crohn's disease.

Ansari A, Aslam Z, De Sica A, Smith M, Gilshenan K, Fairbanks L, Marinaki A, Sanderson J, Duley J.

Aliment Pharmacol Ther. 2008 Sep 15;28(6):749-57. doi: 10.1111/j.1365-2036.2008.03768.x.

Supplemental Content

Support Center